Skip to main content
. 2018 Feb 9;8:2717. doi: 10.1038/s41598-018-21252-w

Figure 5.

Figure 5

Effect of central administration of CHA on the hypothalamic neurons. Representative photographs show cellular activation marker c-Fos (green), orexin (ORX) or melanin concentrating hormone (MCH) immunoreactivity (red), and merged in the hypothalamus of vehicle-injected WT mice (top row), 0.02 nmol of CHA-injected WT mice (second row), 0.02 nmol of CHA-injected ORX-AB mice (third row), and 0.2 nmol of CHA-injected ORX-AB mice (bottom row). Horizontal bar indicates 500 µm. Note absence of orexin-immunoreactivity in ORX-AB mice (left end column, bottom 2 rows).